Self-amplifying nanomedicine reprograms redox metabolism to trigger immunogenic ferroptosis in colon cancer: multiomics identifies AMPD3 as a novel regulator
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Ferroptosis and cancer prognosis
Advanced Nanomaterials in Catalysis
Publication details
- Journal / source
- Biomaterials
- Publisher
- Elsevier BV
- Volume
- 333
- Pages
- 124196–124196
- Publication date
- 2 April 2026
- Language
- EN